This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
BCAN TT 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Conference Highlights
AUA 2019
AUA 2019
Prostate Cancer
Bladder Cancer
Renal Cancer
Testis & Penile Cancers
Lower Urinary Tract Conditions
GU Reconstruction
Infections & Inflammation
Laparoscopic – Robotic Surgery
Sexual Function
Stone Disease
Press Releases
AUA 2019 Bladder Cancer
Viewing 1-20 of 36 articles
AUA 2019: The Impact of Histological Variants on Survival in Upper Urinary Tract Urothelial Carcinoma Patients Treated with Nephroureterectomy: A Multicenter Collaboration
AUA 2019: Percutaneous Biopsy for Upper Tract Urothelial Carcinoma - Safety and Diagnostic Accuracy
AUA 2019: Perioperative and Oncologic Outcome of Upper Tract Urothelial Carcinoma with Variant Histology following Radical Nephroureterectomy
AUA 2019: The Unexpected Role of the Urinary Microbiome in Bladder Cancer Immunotherapy Efficacy
AUA 2019: Role of Diffusion-Weighted MRI in Predicting ≥pT2 and ≥pT3 Upper Tract Urothelial Cancer
AUA 2019: Propensity Score Matched Comparison of Oncologic and Functional Outcomes Between Radical Nephroureterectomy and Segmental Ureterectomy
AUA 2019: Prospective Phase IIl Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients with High-Grade UTUC
AUA 2019: Preliminary Phase 2 Results of IL-15RαFc Superagonist N-803 with BCG in BCG-unresponsive NMIBC Patients Demonstrates 82% CR CIS
AUA 2019: Contemporary Analysis of Ureteroenteric Strictures after Open and Robot-Assisted Radical Cystectomy: A Population-Based Study
AUA 2019: Topical Treatment for High-Grade Upper Tract Cytology with Negative Imaging
AUA 2019: IDENTIFY: The Investigation and Detection of Urological Neoplasia in Patients Referred with Suspected Urinary Tract Cancer: A Multicentre Analysis
AUA 2019: The Role of Cutaneous Ureterostomy Diversion: A Multicenter Analysis
AUA 2019: Can We Predict pT0 After NAC in Patients with MIBC? A Challenge of Optimal Candidate Selection for Bladder Preservation Therapy
AUA 2019: Pretreatment Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcome in Chemo-resistant Urothelial Carcinoma Patients Treated with Pembrolizumab
AUA 2019: Role of Adjuvant Cisplatin-based Chemotherapy Following Radical Cystectomy in Muscle-invasive and Locally Advanced Bladder Cancer
AUA 2019: BCG Unresponsive Non-Muscle Invasive Bladder Cancer
AUA 2019: Three Papers in the Past Year that Influenced My Practice in Urothelial Cancer
AUA 2019: Engaging Stakeholders in Urologic Research: The Patient-Centered Design of a Pragmatic Clinical Trial in Bladder Cancer
AUA 2019: Journal of Urology Top Papers: Testis, Bladder and Renal Cancer
AUA 2019: Investigation of PO Agents for Cystoscopic Evaluation of Ureteral Jets
1
2
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free